Par Pharmaceutical, Inc. recalls Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate table…
- Recall date
- September 27, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0122-2017
- FDA classification
- Class III
- Brand / firm
- Par Pharmaceutical, Inc.
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Subpotent Drug; Ethinyl Estradiol
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate tablets, USP 75 mg), 6 blisters (28 count), NDC 0603-7608-17, Rx only, Manufactured in Canada By: Patheon, Inc., Ontario, Canada L5N 7K9, Manufactured for QUALITEST PHARMACEUTICALS, USA, Huntsville, AL 35811
Get recall alerts
Free email alert whenever Par Pharmaceutical, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Par Pharmaceutical, Inc.